China cracks fake COVID-19 vaccine ring, confiscates 3,000 doses—Xinhua | Inquirer ºÚÁÏÉç

ºÚÁÏÉç

China cracks fake COVID-19 vaccine ring, confiscates 3,000 doses—Xinhua

/ 10:48 AM February 02, 2021

SHANGHAI — Chinese police arrested more than 80 people and confiscated over 3,000 fake doses of COVID-19 vaccine as part of a campaign to combat vaccine-related crimes, state news agency Xinhua reported.

The suspects had been carrying out the ruse since at least September last year, Xinhua said on Monday, adding that all fake doses had been tracked down.

The fake vaccines were made by injecting saline into syringes, it said. The suspects may have intended to send the vaccines abroad, the government-backed Global Times newspaper reported, citing a source close to a major Chinese vaccine producer.

Article continues after this advertisement

The police operation was carried out by police in multiple places including Beijing, Shanghai and the eastern province of Shandong, Xinhua said.

Countries around the world have been rolling out vaccine programs in the hope of bringing the year-long coronavirus pandemic to an end.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the and acknowledge that I have read the .

For more news about the novel coronavirus click
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this

www
business
www
business
sports
TAGS: China, Coronavirus, COVID-19

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the and acknowledge that I have read the .

© Copyright 1997-2024 ºÚÁÏÉç | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies.